These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33301930)

  • 21. Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
    Lally L; Forbess L; Hatzis C; Spiera R
    Arthritis Rheumatol; 2016 Oct; 68(10):2550-4. PubMed ID: 27159185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
    Vallet S; Hoyle NR; Kyle RA; Podar K; Pecherstorfer M
    Leuk Lymphoma; 2018 Oct; 59(10):2431-2438. PubMed ID: 29345175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
    Devauchelle-Pensec V; Saraux L; Berthelot JM; De Bandt M; Cornec D; Guellec D; Marhadour T; Jousse-Joulin S; Gouillou M; Saraux A
    Rheumatology (Oxford); 2018 Apr; 57(4):666-670. PubMed ID: 29346621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.
    Lingaiah S; Morin-Papunen L; Risteli J; Tapanainen JS
    Fertil Steril; 2019 Aug; 112(2):362-370. PubMed ID: 31227287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
    J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.
    Eastell R; Mitlak BH; Wang Y; Hu M; Fitzpatrick LA; Black DM
    Osteoporos Int; 2019 Mar; 30(3):667-673. PubMed ID: 30635696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
    Szulc P; Naylor K; Hoyle NR; Eastell R; Leary ET;
    Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective control of polymyalgia rheumatica with tocilizumab.
    Al Rashidi A; Hegazi MO; Mohammad SA; Varghese A
    J Clin Rheumatol; 2013 Oct; 19(7):400-1. PubMed ID: 24048113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
    Mori S; Koga Y
    Clin Rheumatol; 2016 May; 35(5):1367-75. PubMed ID: 24803231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
    Chen YM; Chen HH; Huang WN; Liao TL; Chen JP; Chao WC; Lin CT; Hung WT; Hsieh CW; Hsieh TY; Chen YH; Chen DY
    PLoS One; 2017; 12(11):e0188454. PubMed ID: 29155868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition.
    Camellino D; Soldano S; Cutolo M; Cimmino MA
    Rheumatol Int; 2018 Sep; 38(9):1699-1704. PubMed ID: 29946742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study.
    Fassio A; Adami G; Giollo A; Viapiana O; Malavolta N; Saviola G; Bortolotti R; Idolazzi L; Bertoldo F; Rossini M; Gatti D
    Calcif Tissue Int; 2020 Apr; 106(4):371-377. PubMed ID: 31897527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on treatment of polymyalgia rheumatica.
    Camellino D; Dejaco C
    Reumatismo; 2018 Mar; 70(1):59-66. PubMed ID: 29589404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
    Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
    Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.
    Dejaco C; Brouwer E; Mason JC; Buttgereit F; Matteson EL; Dasgupta B
    Nat Rev Rheumatol; 2017 Oct; 13(10):578-592. PubMed ID: 28905861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.